University of Maryland Greenebaum Cancer Center — Baltimore, Maryland

Public research footprint of University of Maryland Greenebaum Cancer Center, compiled from the ClinicalTrials.gov public registry.

404

Registered studies

170

Active

Recruiting now

179

Completed

Stopped or withdrawn

Most-studied conditions

Malignant Solid Neoplasm · Recurrent Malignant Female Reproductive System Neoplasm · Lung Non-Small Cell Carcinoma · Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8

Recently updated registry entries

NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT05554328 — Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Maryland Greenebaum Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.